Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacy
Authors
Keywords
-
Journal
Future Microbiology
Volume 10, Issue 7, Pages 1111-1123
Publisher
Future Medicine Ltd
Online
2015-06-29
DOI
10.2217/fmb.15.39
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections
- (2015) William O’Riordan et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolones
- (2014) Françoise Van Bambeke ANNALS OF MEDICINE
- Comparison of the Antibiotic Activities of Daptomycin, Vancomycin, and the Investigational Fluoroquinolone Delafloxacin against Biofilms from Staphylococcus aureus Clinical Isolates
- (2014) Wafi Siala et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A new strategy to fight antimicrobial resistance: the revival of old antibiotics
- (2014) Nadim Cassir et al. Frontiers in Microbiology
- A Combined Pharmacodynamic Quantitative and Qualitative Model Reveals the Potent Activity of Daptomycin and Delafloxacin against Staphylococcus aureus Biofilms
- (2013) Julia Bauer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Global Spread of Healthcare-Associated Multidrug-Resistant Bacteria: A Perspective From Asia
- (2013) James S. Molton et al. CLINICAL INFECTIOUS DISEASES
- Clinical relevance of the ESKAPE pathogens
- (2013) Jack N Pendleton et al. Expert Review of Anti-Infective Therapy
- Antibiotics in the clinical pipeline in 2013
- (2013) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- New antibiotic agents in the pipeline and how they can help overcome microbial resistance
- (2013) Ian M. Gould et al. Virulence
- Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization
- (2012) J. M. Remy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Staphylococcus aureus
- (2011) Sofia Costa et al. BMC MICROBIOLOGY
- Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective
- (2011) Johan W. Mouton et al. DRUG RESISTANCE UPDATES
- Staphylococcus aureusbiofilms
- (2011) Nathan K. Archer et al. Virulence
- Overexpression ofpatAandpatB, Which Encode ABC Transporters, Is Associated with Fluoroquinolone Resistance in Clinical Isolates ofStreptococcus pneumoniae
- (2010) Mark I. Garvey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contrasting Effects of Acidic pH on the Extracellular and Intracellular Activities of the Anti-Gram-Positive Fluoroquinolones Moxifloxacin and Delafloxacin againstStaphylococcus aureus
- (2010) Sandrine Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin in the 21st century
- (2009) Roger L Nation et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Staphylococcus aureus: new evidence for intracellular persistence
- (2009) Christian Garzoni et al. TRENDS IN MICROBIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now